A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells

The oncolytic herpes simplex virus (HSV) that has been approved for clinical practice and those HSVs in clinical trials are attenuated viruses, often with the neurovirulence gene γ(1)34.5 and additional genes deleted. One strategy to engineer nonattenuated oncolytic HSVs consists of retargeting the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Virol
Asıl Yazarlar: Leoni, Valerio, Gatta, Valentina, Casiraghi, Costanza, Nicosia, Alfredo, Petrovic, Biljana, Campadelli-Fiume, Gabriella
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2017
Konular:
Gene Delivery
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5411604/
https://ncbi.nlm.nih.gov/pubmed/28250120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00067-17
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller